Liquid Biopsy Market is expected to reach USD 9.34 billion by 2032
Introduction The liquid biopsy market has emerged as one of the most transformative areas within modern healthcare and diagnostics. Unlike traditional tissue biopsies, liquid biopsy is a non-invasive procedure that analyzes biomarkers in blood or other body fluids to detect cancers, genetic disorders, and other medical conditions. Its ability to provide real-time insights into disease...
0 Commentarios 0 Acciones 16 Views 0 Vista previa